Comprehensive genomic analysis of desmoplastic medulloblastomas: Identification of novel amplified genes and separate evaluation of the different histological components

Journal of Pathology

Volumn 208, Issue 4, 2006, Pages 554-563

  Ehrbrecht, A ^a   Muller U ^b   Wolter, M ^c   Hoischen, A ^a   Koch, A ^a   Radlwimmer, B ^b   Actor, B ^b   Mincheva, A ^b   Pietsch, T ^a   Lichter, P ^b   Reifenberger, G ^c   Weber, Ruthild G ^a  

^a UNIVERSITY OF BONN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Comparative genomic hybridization; Gene amplification; Medulloblatosma; Molecular genetics; RPS6KB1

Indexed keywords

AMYLOID PRECURSOR PROTEIN BINDING PROTEIN 2; BINDING PROTEIN; BREAST CARCINOMA AMPLIFIED SEQUENCE 3; DNA; MAGNESIUM DEPENDENT PHOSPHOPROTEIN PHOSPHATASE 1D; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PATCHED; S6 KINASE; SONIC HEDGEHOG PROTEIN; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMPLICON; ARTICLE; CEREBELLUM TUMOR; CHILD; CHROMOSOME 10; CHROMOSOME 12P; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 22; CHROMOSOME 3; CHROMOSOME 5P; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DESMOPLASTIC MEDULLOBLASTOMA; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEDULLOBLASTOMA; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; X CHROMOSOME; Y CHROMOSOME;

BASE SEQUENCE; CEREBELLAR NEOPLASMS; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MEDULLOBLASTOMA; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA;

EID: 33644670527     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1925     Document Type: Article

References (66)

1. Giangaspero F. Medulloblastoma. WHO Classification of Tumours: Tumours of the Nervous System. WHO: Lyon, 2000; 129-137.
2. Buhren J, Christoph AH, Buslei R, Albrecht S, Wiestler OD, Pietsch T. Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer. J Neuropathol Exp Neurol 2000;59:229-240.
3. Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J, et al. Prospective randomized trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995;25:166-178.
4. Sure U, Berghorn WJ, Bertalanffy H, Wakabayashi T, Yoshida J, Sugita K, et al. Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institute. Acta Neurochir (Wien) 1995;132:59-65.
5. Jenkin D, Shabanah MA, Shail EA, Gray A, Hassounah M, Khafaga Y, et al. Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys 2000;47:573-584.
6. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978-986.
7. Bigner SH, McLendon RE, Fuchs H, McKeever PE, Friedman HS. Chromosomal characteristics of childhood brain tumors. Cancer Genet Cytogenet 1997;97:125-134.
8. Pietsch T, Waha A, Koch A, Kraus J, Albrecht S, Tonn J, et al. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 1997;57:2085-2088.
9. Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, et al. Sporadic medulloblastomas contain PTCH mutations. Cancer Res 1997;57:842-845.
10. Wolter M, Reifenberger J, Sommer C, Ruzicka. T, Reifenberger G. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1997;57:2581-2585.
11. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, et al. Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002;31:306-310.
12. Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998;58:1798-1803.
13. Huang H, Mahler-Araujo BM, Sankila A, Chimelli L, Yonekawa Y, Kleihues P, et al. APC mutations in sporadic medulloblastomas. Am J Pathol 2000;156:433-437.
14. Koch A, Waha A, Tonn JC, Sorensen N, Berthold F, Wolter M, et al. Somatic mutations of WNT/wingless signalling pathway components in primitive neuroectodermal tumors. Int J Cancer 2001;93:445-449.
15. Zurawel RH, Allen C, Chiappa S, Cato W, Biegel J, Cogen P, et al. Analysis of PTCHISMOISHH pathway genes in medulloblastoma. Genes Chromosomes Cancer 2000;27:44-51.
16. Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F, et al. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 2001;61:7039-7043.
17. Baeza N, Masuoka J, Kleihues P, Ohgaki H. AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 2003;22:632-636.
18. Pietsch T, Taylor MD, Rutka JT. Molecular pathogenesis of childhood brain tumors. J Neurooncol 2004;70:203-215.
19. Wechsler-Reya RJ, Scott MP. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 1999;22:103-114.
20. Ruiz i Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2002;2:361-372.
21. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821.
22. du Manoir S, Speicher MR, Joos S, Schrock E, Popp S, Dohner H, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993;90:590-610.
23. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997;20:399-407.
24. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-211.
25. Sambrook JE, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989.
26. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, et al. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003;163:1033-1043.
27. Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP. Refined mapping of 12ql3-ql5 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 1996;56:5141-5145.
28. Weber RG, Scheer M, Born IA, Joos S, Cobbers JM, Hofele C, et al. Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol 1998; 153:295-303.
29. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Turmacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992;13:718-725.
30. Weber T, Weber RG, Kaulich K, Actor B, Meyer-Puttlitz B, Lampel S, et al. Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type. Brain Pathol 2000;10:73-84.
31. Lichter P, Bentz M, Joos S. Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization. Methods Enzymol 1995;254:334-359.
32. du Manoir S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T, et al. Quantitative analysis of comparative genomic hybridization. Cytometry 1995;19:27-41.
33. Knight SJ, Lese CM, Precht KS, Kuc J, Ning Y, Lucas S, et al. An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet 2000;67:320-332.
34. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 2003;36:361-374.
35. Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 2004;101:1039-1044.
36. Wessendorf S, Fritz B, Wrobel G, Nessling M, Lampel S, Goettel D, et al. Automated screening for genomic imbalances using matrix-based comparative genomic hybridization. Lab Invest 2002;82:47-60.
37. Cobbers JM, Wolter M, Reifenberger J, Ring GU, Jessen F, An HX, et al. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Brain Pathol 1998;8:263-276.
38. Wolter M, Reifenberger J, Blaschke B, Ichimura. K, Schmidt EE, Collins VP, et al. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes. J Neuropathol Exp Neurol 2001;60:1170-1180.
39. Biegel JA, Rorke LB, Packer RJ, Sutton LN, Schut L, Bonner K, et al. Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer 1989;1:139-147.
40. Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST, et al. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 1997;57:4042-4047.
41. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, et al. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 1999;86:331-339.
42. Avet-Loiseau H, Venuat AM, Terrier-Lacombe MJ, Lellouch-Tubiana A, Zerah M, Vassal G. Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children. Br J Cancer 1999;79:1843-1847.
43. Adesina AM, Nalbantoglu J, Cavenee WK. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma. Cancer Res 1994;54:5649-5651.
44. Waha A, Koch A, Meyer-Puttlitz B, Weggen S, Sorensen N, Tonn JC, et al. Epigenetic silencing of the HIC-1 gene in human medulloblastomas. J Neuropathol Exp Neurol 2003;62:1192-1201.
45. Schutz BR, Scheurlen W, Krauss J, du Manoir S, Joos S, Bentz M, et al. Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer 1996;16:196-203.
46. Brown HG, Kepner JL, Perlman EJ, Friedman HS, Strother DR, Duffner PK, et al. 'Large cell/anaplastic' medulloblastomas: a Pediatric Oncology Group Study. J Neuropathol Exp Neurol 2000;59:857-865.
47. Aldosari N, Bigner SH, Burger PC, Becker L, Kepner JL, Friedman HS, et al. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med 2002;126:540-544.
48. Michiels EM, Weiss MM, Hoovers JM, Baak JP, Voute PA, Baas F, et al. Genetic alterations in childhood medulloblastoma. analysed by comparative genomic hybridization. J Pediatr Hematol Oncol 2002;24:205-210.
49. Tong CY, Hui AB, Yin XL, Pang JC, Zhu XL, Poon WS, et al. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J Neurosurg Spine 2004;100: 187-193.
50. Iolascon A, Lania A, Badiali M, Pession A, Saglio G, Giangaspero F, et al. Analysis of N-ras gene mutations in medulloblastomas by polymerase chain reaction and oligonucleotide probes in formalin-fixed, paraffin-embedded tissues. Med Pediatr Oncol 1991;19:240-245.
51. Nishizaki T, Harada K, Kubota H, Ozaki S, Ito H, Sasaki K. Genetic alterations in pediatric medulloblastomas detected by comparative genomic hybridization. Pediatr Neurosurg 1999;31:27-32.
52. Eberhart CG, Kratz JE, Schuster A, Goldthwaite P, Cohen KJ, Perlman EJ, et al. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 2002;12:36-44.
53. Knobbe CB, Reifenberger G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 2003;13:507-518.
54. Fan X, Wang Y, Kratz J, Brat DJ, Robitaille Y, Moghrabi A, et al. hTERT ne amplification and increased mRNA expression in central nervous system embryonal tumors. Am J Pathol 2003;162:1763-1769.
55. + Hodgkin cells. Cancer Res 2000; 60:549-552.
56. Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, Imamura M, et al. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in oesophageal cancer cell lines. Cancer Res 2000;60:4735-4739.
57. Sinclair CS, Rowley M, Naderi A, Couch FJ. The 17q23 amplicon and breast cancer. Breast Cancer Res Treat 2003;78:313-322.
58. Watanabe T, Imoto I, Kosugi Y, Ishiwata I, Inoue S, Takayama M, et al. A novel amplification at 17q21-23 in ovarian cancer cell lines detected by comparative genon-& hybridization. Gynecol Oncol 2001;81:172-177.
59. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningionta progression. Proc Natl Acad Sci USA 1997;94:14719-14724.
60. Khan J, Parsa NZ, Harada T, Meltzer PS, Carter NP. Detection of gains and losses in 18 meningiomas by comparative genomic hybridization. Cancer Genet Cytogenet 1998;103:95-100.
61. Saito-Ohara F, Imoto I, Inoue J, Hosoi H, Nakagawara A, Sugimoto T, et al. PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res 2003;63:1876-1883.
62. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-1657.
63. Broderick DK, Di C, Parrett TJ, Samuels YR, Cummins JM, McLendon RE, et al. Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 2004;64:5048-5050.
64. Geoerger B, Kerr K, Tang CB, Fung KM, Powell B, Sutton LN, et al. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy. Cancer Res 2001;61:1527-1532.
65. Kenney AM, Widlund HR, Rowitch DH. Hedgehog and PI-3 kinase signalling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors. Development 2004;131:217-228.
66. Rao G, Pedone CA, Valle LD, Reiss K, Holland EC, Fults DW. Sonic hedgehog and insulin-like growth factor signalling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004;23:6156-6162.